These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33905012)

  • 1. Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management.
    Homan MJ; Reid JH; Nachar VR; Benitez LL; Brown AM; Kraft S; Hough S; Christen C; Frame D; McDevitt RL
    Support Care Cancer; 2021 Nov; 29(11):6505-6510. PubMed ID: 33905012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Feasibility and Utility of a Pharmacist-Centered Collaborative Drug Therapy Management Program for Oncology-Based Symptom Management.
    Hansen EA; Pietkiewicz JM; Blum BL
    J Pharm Pract; 2016 Jun; 29(3):206-11. PubMed ID: 25510586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
    Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
    J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of pharmacist interventions in an ambulatory palliative care practice.
    Ma JD; Tran V; Chan C; Mitchell WM; Atayee RS
    J Oncol Pharm Pract; 2016 Dec; 22(6):757-765. PubMed ID: 26428283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist management of antiemetic therapy under protocol in an oncology clinic.
    Martin JK; Norwood MB
    Am J Hosp Pharm; 1988 Jun; 45(6):1322-8. PubMed ID: 3414699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Role of a Clinical Pharmacist on Medication Management in an Adult Burn Clinic via a Collaborative Drug Therapy Management Protocol.
    Boyd AN; Kadi BA; Rothenberger MA; Hartman BC; Spera LJ; Meadows KJ; Walroth TA
    J Burn Care Res; 2023 Sep; 44(5):1023-1030. PubMed ID: 37300486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers interfering with establishment of Collaborative Drug Therapy Management (CDTM) agreements between clinical pharmacists and physicians.
    Alhossan A; Alazba A
    Saudi Pharm J; 2019 Jul; 27(5):713-716. PubMed ID: 31297026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.
    Umar RM; Apikoglu-Rabus S; Yumuk PF
    Int J Clin Pharm; 2020 Apr; 42(2):652-661. PubMed ID: 32078106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of pharmacist clinical services to optimize the management of immune checkpoint inhibitor toxicities.
    Renna CE; Dow EN; Bergsbaken JJ; Leal TA
    J Oncol Pharm Pract; 2019 Jun; 25(4):954-960. PubMed ID: 30975067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
    Holle LM; Puri S; Clement JM
    J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pharmacist-managed immune checkpoint inhibitor toxicities.
    Le S; Chang B; Pham A; Chan A
    J Oncol Pharm Pract; 2021 Apr; 27(3):596-600. PubMed ID: 32507100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of a Clinical Pharmacist into an Interdisciplinary Palliative Care Outpatient Clinic.
    DiScala SL; Onofrio S; Miller M; Nazario M; Silverman M
    Am J Hosp Palliat Care; 2017 Nov; 34(9):814-819. PubMed ID: 27418599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an ambulatory palliative care pharmacist practice.
    Atayee RS; Best BM; Daniels CE
    J Palliat Med; 2008 Oct; 11(8):1077-82. PubMed ID: 18980446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
    Lam MS; Cheung N
    J Oncol Pharm Pract; 2016 Dec; 22(6):741-748. PubMed ID: 26419691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?
    Ruder AD; Smith DL; Madsen MT; Kass FH
    J Oncol Pharm Pract; 2011 Dec; 17(4):425-32. PubMed ID: 21248174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentered Evaluation of Palliative Care Pharmacists' Interventions and Outcomes in California.
    Malotte K; Naidu DR; Herndon CM; Atayee RS
    J Palliat Med; 2021 Sep; 24(9):1358-1363. PubMed ID: 33625895
    [No Abstract]   [Full Text] [Related]  

  • 18. Survey of pharmacist collaborative drug therapy management in hospitals.
    Thomas J; Bharmal M; Lin SW; Punekar Y
    Am J Health Syst Pharm; 2006 Dec; 63(24):2489-99. PubMed ID: 17158697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Multidisciplinary Treatment-Related Adverse Effects Detection and Reduction in Patients Undergoing Active Cancer Treatments in Ambulatory Infusion Centers.
    Chung C; Rome A; Desai M; Abanonu F; De la Casas C
    JCO Oncol Pract; 2022 Sep; 18(9):e1553-e1561. PubMed ID: 35776902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-led collaborative medication management programs for oral antineoplastic therapies: A systematic literature review.
    Passey DG; Healy R; Qualls J; Halwani A; Sauer BC
    J Am Pharm Assoc (2003); 2021; 61(3):e7-e18. PubMed ID: 33358357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.